ScoreWhy is Hualan Biological Vaccine, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -22.59% and Operating profit at -147.19% over the last 5 years
2
The company has declared Negative results for the last 4 consecutive quarters
- NET PROFIT(HY) At CNY 90.44 MM has Grown at -58.85%
- OPERATING CASH FLOW(Y) Lowest at CNY 399.97 MM
- NET SALES(HY) At CNY 780.31 MM has Grown at -15.47%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Hualan Biological Vaccine, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Hualan Biological Vaccine, Inc.
14.55%
0.17
52.35%
China Shanghai Composite
16.1%
1.26
12.73%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-22.59%
EBIT Growth (5y)
-147.19%
EBIT to Interest (avg)
70.38
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
0.25
Tax Ratio
3.33%
Dividend Payout Ratio
58.21%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.43%
ROE (avg)
9.48%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
56
Industry P/E
Price to Book Value
1.73
EV to EBIT
80.40
EV to EBITDA
30.99
EV to Capital Employed
2.50
EV to Sales
6.28
PEG Ratio
NA
Dividend Yield
0.27%
ROCE (Latest)
3.12%
ROE (Latest)
3.08%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET SALES(Q)
At CNY 746.03 MM has Grown at 159.62%
PRE-TAX PROFIT(Q)
At CNY 121.59 MM has Grown at 169.06%
NET PROFIT(Q)
At CNY 107.25 MM has Grown at 135.46%
-20What is not working for the Company
NET PROFIT(HY)
At CNY 90.44 MM has Grown at -58.85%
OPERATING CASH FLOW(Y)
Lowest at CNY 399.97 MM
NET SALES(HY)
At CNY 780.31 MM has Grown at -15.47%
ROCE(HY)
Lowest at 1.2%
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.64 times
Here's what is working for Hualan Biological Vaccine, Inc.
Net Sales
At CNY 746.03 MM has Grown at 159.62%
over average net sales of the previous four periods of CNY 287.35 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (CNY MM)
Pre-Tax Profit
At CNY 121.59 MM has Grown at 169.06%
over average net sales of the previous four periods of CNY 45.19 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 107.25 MM has Grown at 135.46%
over average net sales of the previous four periods of CNY 45.55 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Here's what is not working for Hualan Biological Vaccine, Inc.
Operating Cash Flow
Lowest at CNY 399.97 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debtors Turnover Ratio
Lowest at 0.64 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
